1. Home
  2. BCYC vs URG Comparison

BCYC vs URG Comparison

Compare BCYC & URG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • URG
  • Stock Information
  • Founded
  • BCYC 2009
  • URG 2004
  • Country
  • BCYC United Kingdom
  • URG United States
  • Employees
  • BCYC N/A
  • URG N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • URG Precious Metals
  • Sector
  • BCYC Health Care
  • URG Basic Materials
  • Exchange
  • BCYC Nasdaq
  • URG Nasdaq
  • Market Cap
  • BCYC 492.1M
  • URG 565.5M
  • IPO Year
  • BCYC 2019
  • URG N/A
  • Fundamental
  • Price
  • BCYC $6.92
  • URG $1.48
  • Analyst Decision
  • BCYC Buy
  • URG Strong Buy
  • Analyst Count
  • BCYC 11
  • URG 3
  • Target Price
  • BCYC $22.91
  • URG $2.63
  • AVG Volume (30 Days)
  • BCYC 213.9K
  • URG 6.7M
  • Earning Date
  • BCYC 10-30-2025
  • URG 11-05-2025
  • Dividend Yield
  • BCYC N/A
  • URG N/A
  • EPS Growth
  • BCYC N/A
  • URG N/A
  • EPS
  • BCYC N/A
  • URG N/A
  • Revenue
  • BCYC $19,281,000.00
  • URG $39,488,000.00
  • Revenue This Year
  • BCYC N/A
  • URG N/A
  • Revenue Next Year
  • BCYC N/A
  • URG $232.02
  • P/E Ratio
  • BCYC N/A
  • URG N/A
  • Revenue Growth
  • BCYC N/A
  • URG 149.20
  • 52 Week Low
  • BCYC $6.10
  • URG $0.55
  • 52 Week High
  • BCYC $28.67
  • URG $1.62
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 41.28
  • URG 56.96
  • Support Level
  • BCYC $6.77
  • URG $1.42
  • Resistance Level
  • BCYC $7.32
  • URG $1.60
  • Average True Range (ATR)
  • BCYC 0.39
  • URG 0.08
  • MACD
  • BCYC 0.01
  • URG -0.00
  • Stochastic Oscillator
  • BCYC 19.04
  • URG 50.00

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About URG Ur Energy Inc (Canada)

Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project.

Share on Social Networks: